PATENT CLAIM ANALYSIS

Application Number: 15979320
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "021600"]

Abstract:
Neurokinin 1 receptor (NK1R) agonist mediated protection of the eye is described. The protection can reduce dry eye and ocular infections, particularly in individuals with reduced NK1R activity.

Claim (Index 4):
A method of  claim 3 , wherein the condition is alcoholism, Sezary Syndrome, epidermolysis Bullosa, nausea, vomiting, post-traumatic stress disorder, or HIV infection.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14821567', '14071559', '14768885', '13318805', '14284911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7152149965914906
- 35 USC 102 Novelty (BERT): 0.5133153671164985
- Combined Prediction Score: 0.6950250336439914
- Mean Citation Score: 171.96081800000005
- Max Citation Score: 178.52194
- Similarity Product: 100.72279927489876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test